Systemic vasculitis
Inflammation and necrosis of blood vessels, classified by vessel size.
Systemic vasculitis, also called systemic necrotizing vasculitis, is a general term for the inflammation of veins and arteries that develops into necrosis and narrows the vessels. It encompasses a group of disorders classified by the size of the blood vessels primarily affected—large, medium, small, or variable—and includes conditions such as Takayasu's arteritis, giant cell arteritis, polyarteritis nodosa, Kawasaki disease, and various forms of small vessel vasculitis. These diseases are significant because they can cause widespread damage, including blood clots, aneurysms, bleeding, artery blockage, and numerous systemic symptoms like fever, weight loss, and exhaustion.
Quick Facts
- Field
- Immunology, rheumatology
Facts from the source article.
Lore & Background
The first detailed description of systemic necrotizing arteritis was provided by Kussmaul and Maier in 1866. In 1919, Karl Theodor Fahr described acute arterial lesions always present in malignant nephrosclerosis, noting that these injuries were most severe in the kidneys and occurred less frequently in other organs such as the pancreas, adrenal glands, and intestines. Fahr believed necrotizing arteriolitis was the primary cause of the lesions, malignant necrosis, and high blood pressure by narrowing the kidney vascular bed.
Reader's Guide
Systemic vasculitis represents a critical category in medical understanding because it encompasses a diverse set of disorders that share a common pathological process—inflammation and necrosis of blood vessel walls—but differ in the vessels affected, underlying mechanisms, and clinical presentations. The 2012 Chapel Hill Consensus Conference classification into large-, medium-, small-, and variable-vessel vasculitis provides a framework for diagnosis and treatment. Recognized triggers include tumors, medications, allergic reactions, and infectious organisms, though the precise cause of many forms remains unknown. Pathogenetic factors such as immune complex disease, anti-neutrophil cytoplasmic antibodies, anti-endothelial cell antibodies, and cell-mediated immunity have been identified. The legacy of systemic vasculitis research lies in its contribution to understanding autoimmune and inflammatory diseases, with conditions like giant cell arteritis being the most common systemic vasculitis in adults, and Kawasaki disease primarily affecting young children. The variability in symptoms—from life-threatening kidney failure or massive bleeding to nonspecific signs like rash, fever, and joint pain—underscores the importance of early recognition and classification.
Did You Know?
- Systemic necrotizing vasculitis was first described in detail by Kussmaul and Maier in 1866.
- Giant cell arteritis is the most common type of systemic vasculitis in adults.
- Kawasaki disease primarily affects young children and presents with fever, conjunctivitis, and swollen lymph nodes.
- Anti-glomerular basement membrane disease is also known by the eponym 'Goodpasture syndrome'.
More in Vasculitis 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced